期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

转移性肾细胞癌药物治疗方法的研究 被引量：2

Drug therapy of metastatic renal cell carcinoma
下载PDF
导出
摘要 肾细胞癌在我国的发病率逐年升高,且对于放化疗不敏感,免疫治疗效果有限,尤其是转移性肾细胞癌的预后较差。该文就转移性肾细胞癌的药物治疗方案的作用机制、现状及展望进行综述。 The incidence of renal cell carcinoma in China increases year by year. Renal cell carcinoma is not sensitive to radiation and chemotherapy,and the effect of immunotherapy is also limited,especially for the metastatic renal cell carcinoma. The objective of this paper is to discuss the drug therapy and mechanism of metastatic renal cell carcinoma and to summarize the status quo and prospects.
作者 吕香君 张旭
机构地区 中国人民解放军医学院
出处 《安徽医药》 CAS 2014年第5期793-796,共4页 Anhui Medical and Pharmaceutical Journal
关键词 转移性肾细胞癌 药物治疗 metastatic renal cell carcinoma drug therapy
分类号 R737.11 [医药卫生—肿瘤]
  • 相关文献

参考文献23

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics,2012 [ J ]. CA Cancer J Clin,2012,62 ( 1 ) : 10 - 29.
  • 2Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J 1- CA Cancer J Clin,2011,61 ( 2 ) :69 - 90.
  • 3Escudier B, Eisen T, Porta C, et al. Renal cell carcinoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [ J J. Annals of oncology: official journal of the European Society for Medical Ontology,2012,23 ( Suppl 7 ) :vii65 - vii71.
  • 4Atzpodien J, Kirchner H, Jonas U, et al, interleukin-2- and inter- feron alfa-2a-based immunochemotherapy in advanced renal cell cainoma :a Prospectively Randomized Trial of the German Coop- erative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) [J]. J Clin 0ncol,2004,22(7) :1188 -1194.
  • 5Atzpodien J, Schmitt E, Gertenbach U, et al. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmuno- therapy in renal cell carcinoma post tumnur nephrectomy : results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimrnunotherapy Group (DGCIN) I J 1- Br J Cancer,2005,92 ( 5 ) : 843 - 846.
  • 6Wood C, Srivastava P, Bukowski R, et at. An adjuvant autologous therapeutic vaccine ( HSPPC-96 ; vitespen ) versus observation a- lone for patients at high risk of recurrence aher nephreetomy for re- nal cell carcinoma: a multicentre, open-lahel, randomised phase Ill trial [ J ]. Lancet,2008,372 ( 9633 ) : 145 - 154.
  • 7Karr JP, Pontes JE, Schneider S, et al. Clinical aspects of steroid hormone receptors in human renal cell carcinoma I J ]. J Surg On- co1,1983,23 (2) :117 - 124.
  • 8Latif F,Tory K, Gnarra J, et al. Identification of the yon Hippel- Lindau disease tumor suppressor gene I J ]. Science, 1993,260 (5112) :1317 - 1320.
  • 9Kucejova B, Pena-Llopis S, Yamasaki T, et al. Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma [J]. Mol Cancer Res,2011,9(9) :1255 -1265.
  • 10Rini BI, Escudier B,Tomczak P, et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma ( AX- IS) : a randomised phase 3 trial [ J ]. Lancet, 2011 , 378 ( 9807 ) : 1931 - 1939.

二级参考文献11

  • 1唐伟,清岛圭二郎,八尾隆史,恒吉正澄.MMP2、TIMP2在人肾透明细胞癌中的表达及意义[J].中华泌尿外科杂志,2005,26(3):184-187. 被引量：11
  • 2Rojas A,Liu G.Coleman I,et al.IL-6 promotes prostate tumorigene-sis and progression through autocrine cross-activation of IGF-IR[J].0ncogene,2011,30(20):2345 -55.
  • 3Hartoq H,Wesseling J,Boezen HM,et al.The insulin-like growth factor 1 receptor in cancer:old focus,new future[J].Eur J Cancer,2007,43(13):1895-904.
  • 4Sichani MM,Yazdi FS,Moghaddam NA.et al.Prognostic value of insulin-like growth factor-I receptor expression in renal cell carcino-ma[J].Saudi J Kidney Dis Traspl,2010,21(1):69 -74.
  • 5Johnson JL.Matrix metalloproteinases:influence on smooth muscle cells and atherosclerotic plaque stability[J].Expert Rev Cardiovasc Ther,2007,5(2):265-82.
  • 6Bhuvarahamurthy V,Kristiansen GO,Johannsen M,et al.In situ gene expression and localization of metalloproteinases MMP1,MMP2,MMP3,MMP9,and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma[J].Oncol Rep,2006,15 (5):1379-84.
  • 7Zhang D,Bar-Eli M,Meloche S,et al.Dual regulation of MMP-2 ex-pression by the type 1 insulin-like growth factor receptor:the phos-phatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit op-posing signals[J].Biol Chem,2004,279(19):19683-90.
  • 8Thant AA,Wu YY,Vadgama JV,et al.Cancer invasion and angio-genesis by IGF-1-induced MMP-2 and VEGF in human breast canc-er cells[J].AACR Meeting Abs,2004,202:50 -9.
  • 9Grzmil M.Hemmerlein B,Thelen P,et al.Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits prolifera-tion and invasion,up-regulates IGF binding protein-3,and suppres-ses MMP-2 expression[J].J Pathol,2004,202(1):50 -9.
  • 10寿张轩,何俏军,褚永权,赵仲生.胃癌组织中基质金属蛋白酶-2和胰岛素样生长因子-1蛋白表达及其意义[J].中华外科杂志,2010,48(10):774-779. 被引量：8

共引文献4

同被引文献50

引证文献2

二级引证文献14

安徽医药
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部